Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Glioblastoma × pembrolizumab × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 35 Expanded_access 1

Sponsor

Cancer Type

Dermatologic 1 CNS 1

Conditions

Melanoma 2 KRAS G12V Mutant Advanced Epithelial Cancers 1 Glioma 1 Glioblastoma 1

Interventions

ulixertinib 1 rindopepimut 1 pembrolizumab 1 mogamulizumab 1 efineptakin alfa 1 Proton Pump Inhibitors 1 Ipilimumab 1 Hydrocortisone 1 Cancer Vaccines 1 Adjuvants, Immunologic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03311542 2018-01-10

Expanded Access for Pembrolizumab (MK-3475)

Center Trials & Treatment

No longer available

CNSDermatologic

Glioblastoma, Glioma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡